ArticleAmerican journal of preventive medicine2024

Access to Medications for Opioid Use Disorder During COVID-19: Retrospective Study of Commercially Insured Patients from 2019-2022.

Shilpa Rajagopal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.